Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07675109 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms. The IRB has established that the investigational device is non-significant risk.
Trial Details
NCT Number NCT07675109
Lead Sponsor Noctrix Health, Inc.
Conditions
(from sponsor)		 Restless Legs Syndrome (RLS)
Related terms Restless Legs Syndrome
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov